MetLife Investment Advisors LLC bought a new position in shares of Livent Corporation (NASDAQ:LTHM) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 16,565 shares of the company’s stock, valued at approximately $229,000.
A number of other institutional investors and hedge funds have also bought and sold shares of LTHM. Athena Capital Advisors LLC acquired a new stake in Livent in the fourth quarter valued at approximately $28,000. PNC Financial Services Group Inc. acquired a new stake in Livent in the fourth quarter valued at approximately $31,000. Glassman Wealth Services acquired a new stake in Livent in the fourth quarter valued at approximately $33,000. Kwmg LLC acquired a new stake in Livent in the fourth quarter valued at approximately $63,000. Finally, Citigroup Inc. acquired a new stake in Livent in the fourth quarter valued at approximately $85,000.
Several analysts have issued reports on LTHM shares. Credit Suisse Group set a $20.00 price objective on shares of Livent and gave the company a “buy” rating in a research report on Friday, January 4th. Clarkson Capital started coverage on shares of Livent in a research report on Wednesday, January 16th. They issued a “buy” rating and a $20.00 price objective for the company. Bank of America set a $16.00 price objective on shares of Livent and gave the company a “buy” rating in a research report on Thursday, February 14th. Loop Capital lowered their price objective on shares of Livent to $18.00 and set a “buy” rating for the company in a research report on Wednesday, February 13th. Finally, Gabelli started coverage on shares of Livent in a research report on Wednesday, February 27th. They issued a “buy” rating and a $21.00 price objective for the company. Five equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. The company currently has an average rating of “Buy” and a consensus target price of $18.71.
Livent (NASDAQ:LTHM) last released its earnings results on Monday, February 11th. The company reported $0.23 EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.23. The business had revenue of $119.80 million for the quarter, compared to analysts’ expectations of $124.70 million.
ILLEGAL ACTIVITY WARNING: “MetLife Investment Advisors LLC Buys Shares of 16,565 Livent Corporation (LTHM)” was first posted by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this story on another domain, it was illegally stolen and reposted in violation of United States and international copyright legislation. The correct version of this story can be accessed at https://sportsperspectives.com/2019/04/20/metlife-investment-advisors-llc-buys-shares-of-16565-livent-corporation-lthm.html.
Livent Corporation manufactures and sells performance lithium compounds that are used primarily in energy storage, specialty polymers, and chemical synthesis application. The company offers lithium compounds for use in applications that have specific performance requirements, including battery-grade lithium hydroxide for use in high performance lithium-ion batteries; and supplies butyllithium, which is used as a synthesizer in the production of polymers and pharmaceutical products, as well as a range of specialty lithium compounds, including high purity lithium metal, which is used in the production of lightweight materials for aerospace applications and non-rechargeable batteries.
Read More: What Does a Sell-Side Analyst Rating Mean?
Receive News & Ratings for Livent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Livent and related companies with MarketBeat.com's FREE daily email newsletter.